Effects of Bilberry and Oat intake on lipids, inflammation and exercise capacity after Acute Myocardial Infarction (BIOAMI): study protocol for a randomized, double-blind, placebo-controlled trial

被引：0
|
作者：
Cecilia Bergh
Rikard Landberg
Kristina Andersson
Lovisa Heyman-Lindén
Ana Rascón
Anders Magnuson
Payam Khalili
Amra Kåregren
Johan Nilsson
Carlo Pirazzi
David Erlinge
Ole Fröbert
机构：
[1] Örebro University,Clinical Epidemiology and Biostatistics, School of Medical Sciences
[2] Chalmers University of Technology,Department of Biology and Biological Engineering, Food and Nutrition Science
[3] Umeå University,Department of Public Health and Clinical Medicine
[4] Lund University,Department of Experimental Medical Science
[5] Glucanova AB,Molecular Nutrition, Department of Experimental Medical Science
[6] Lund University,Department of Food Technology, Engineering and Nutrition
[7] Berry Lab AB,Department of Cardiology and Acute Internal Medicine
[8] Lund University,Department of Medicine
[9] Central Hospital,Department of Cardiology
[10] Hospital Region Västmanland,Department of Cardiology, Clinical Sciences
[11] Sahlgrenska University Hospital,Department of Cardiology, Faculty of Medicine and Health
[12] Lund University,undefined
[13] Örebro University,undefined
来源：
Trials | / 22卷
关键词：
Anthocyanin; Anthocyanin-derived phenolic acid metabolites; Bilberry; Cholesterol; Diet therapy; Exercise test; Inflammation; Myocardial infarction;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Effects of Bilberry and Oat intake on lipids, inflammation and exercise capacity after Acute Myocardial Infarction (BIOAMI): study protocol for a randomized, double-blind, placebo-controlled trial
    Bergh, Cecilia
    Landberg, Rikard
    Andersson, Kristina
    Heyman-Linden, Lovisa
    Rascon, Ana
    Magnuson, Anders
    Khalili, Payam
    Karegren, Amra
    Nilsson, Johan
    Pirazzi, Carlo
    Erlinge, David
    Frobert, Ole
    TRIALS, 2021, 22 (01)
  • [2] Influenza Vaccination After Myocardial Infarction: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial
    Frobert, Ole
    Gotberg, Matthias
    Erlinge, David
    Akhtar, Zubair
    Christiansen, Evald H.
    MacIntyre, Chandini R.
    Oldroyd, Keith G.
    Motovska, Zuzana
    Erglis, Andrejs
    Moer, Rasmus
    Hlinomaz, Ota
    Jakobsen, Lars
    Engstrom, Thomas
    Jensen, Lisette O.
    Fallesen, Christian O.
    Jensen, Svend E.
    Angeras, Oskar
    Calais, Fredrik
    Karegren, Amra
    Lauermann, Jorg
    Mokhtari, Arash
    Nilsson, Johan
    Persson, Jonas
    Stalby, Per
    Islam, Abu K. M. M.
    Rahman, Afzalur
    Malik, Fazila
    Choudhury, Sohel
    Collier, Timothy
    Pocock, Stuart J.
    Pernow, John
    CIRCULATION, 2021, 144 (18) : 1476 - 1484
  • [3] The Effects of Probiotics on Symptoms of Depression: Protocol for a Double-Blind Randomized Placebo-Controlled Trial
    Wallace, Caroline J. K.
    Foster, Jane A.
    Soares, Claudio N.
    Milev, Roumen, V
    NEUROPSYCHOBIOLOGY, 2020, 79 (01) : 108 - 116
  • [4] Hydroxychloroquine reduces interleukin-6 levels after myocardial infarction: The randomized, double-blind, placebo-controlled OXI pilot trial
    Ulander, Lotta
    Tolppanen, Heli
    Hartman, Otto
    Rissanen, Tuomas T.
    Paakkanen, Riitta
    Kuusisto, Jouni
    Anttonen, Olli
    Nieminen, Tuomo
    Yrjola, Jaana
    Ryysy, Ransu
    Drews, Teemu
    Utriainen, Seppo
    Karjalainen, Pasi
    Anttila, Ismo
    Nurmi, Katariina
    Silventoinen, Kristiina
    Koskinen, Miika
    Kovanen, Petri T.
    Lehtonen, Jukka
    Eklund, Kari K.
    Sinisalo, Juha
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2021, 337 : 21 - 27
  • [5] Beneficial effects of RheothRx injection in patients receiving thrombolytic therapy for acute myocardial infarction - Results of a randomized, double-blind, placebo-controlled trial
    Schaer, GL
    Spaccavento, LJ
    Browne, KF
    Krueger, KA
    Krichbaum, D
    Phelan, JM
    Fletcher, WO
    Grines, CL
    Edwards, S
    Jolly, MK
    Gibbons, RJ
    CIRCULATION, 1996, 94 (03) : 298 - 307
  • [6] "Protocol for a phase 2, randomized, double-blind, placebo-controlled, safety and efficacy study of dutogliptin in combination with filgrastim in early recovery post-myocardial infarction": study protocol for a randomized controlled trial
    von Lewinski, Dirk
    Selvanayagam, Joseph B.
    Schatz, Richard A.
    Jilma, Bernd
    Kubica, Jacek
    Povsic, Thomas J.
    Nix, Darrell
    Henauer, Stephan
    Wallner, Markus
    TRIALS, 2020, 21 (01)
  • [7] “Protocol for a phase 2, randomized, double-blind, placebo-controlled, safety and efficacy study of dutogliptin in combination with filgrastim in early recovery post-myocardial infarction”: study protocol for a randomized controlled trial
    Dirk von Lewinski
    Joseph B. Selvanayagam
    Richard A. Schatz
    Bernd Jilma
    Jacek Kubica
    Thomas J. Povsic
    Darrell Nix
    Stephan Henauer
    Markus Wallner
    Trials, 21
  • [8] A double-blind placebo-controlled study of the effects of Lactobacillus acidophilus on plasma lipids
    S J Lewis
    S Burmeister
    European Journal of Clinical Nutrition, 2005, 59 : 776 - 780
  • [9] A double-blind placebo-controlled study of the effects of Lactobacillus acidophilus on plasma lipids
    Lewis, SJ
    Burmeister, S
    EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2005, 59 (06) : 776 - 780
  • [10] Celecoxib adjunctive therapy for acute bipolarmania: a randomized, double-blind, placebo-controlled trial
    Arabzadeh, Somayeh
    Ameli, Niusha
    Zeinoddini, Atefeh
    Rezaei, Farzin
    Farokhnia, Mehdi
    Mohammadinejad, Payam
    Ghaleiha, Ali
    Akhondzadeh, Shahin
    BIPOLAR DISORDERS, 2015, 17 (06) : 606 - 614
12345